The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.

Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...

Bausch + Lomb Corp. (BLCO, BLCO.TO) announced that the U.S. Food and Drug Administration has approved the enVista Envy full range of ...

Bausch + Lomb Corporation , a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has approved the ...

Cooper’s pricing power and cost optimization efforts are expected to drive margin expansion. Read why I reiterate a Buy ...

Good news is, Medicare does cover necessary cataract surgery including the removal of the cataract and the addition of a ...

Extended depth of focus (EDOF) IOLs are similar to multifocal IOL but with less focusing power - and fewer side effects. Glare and halos aren't as big of a problem with EDOF lenses, but their focusing ...

Intraocular lens choice, as facilitated by the surgeon, can connect the patient with the appropriate device for their ...

A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global Intraocular Lens (IOL) market ...

If you're thinking about getting cataract surgery, here's what a renowned ophthalmologist says you should know.

Recent advances have led to intraocular lenses that offer multifocality– the opportunity to have near as well as distance vision, without glasses. Some multifocal lenses are even in the trifocal ...